Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carrimycin combined with conventional therapy for complicated infections in the neurocritical care unit
ChiCTR2100050363Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospita
- Start
- Aug 2021
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of carrimycin in intracranial infection, pulmonary infection and bacterial disease (2 arms), sponsored by Shanghai Sixth People's Hospita. Primary endpoints: Temperature, Clearance rate of carbapenem-resistant organism and 2 more. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
carrimycin
03
Conditions
intracranial infectionpulmonary infectionbacterial disease
Beyond the preview
Go deeper on ChiCTR2100050363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050363.